BridgeBio Oncology Therapeutics Inc. (BBOT) Stock

BridgeBio Oncology Therapeutics Inc. (BBOT) is a Healthcare stock trading at $7.61 (as of 2026-06-18), with a market capitalization of $643.26M and a trailing P/E of -0.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapeutics targeting RAS and PI3Kα malignancies, which are prevalent oncogenes in human tumors. Initially formed as a subsidiary of BridgeBio Pharma, it focuses on precision oncology with a pipeline that includes BBO-8520, BBO-10203, and BBO-11818 programs targeting KRAS and PI3K pathways. The company recently went public through a business combination with Helix Acquisition Corp. II, raising approximately $450 million to advance clinical development. The CEO is Dr. Eli Wallace, and the CSO is Dr. Pedro Beltran.

Valuation — source: SEC EDGAR (first-party)
Price$7.61
Market Cap$643.26M
P/E Ratio-0.0
EV / EBITDA-3.0
Price / Book1.67
Price / Sales46.69
DCF Value (model)$-19.68
DCF Upside vs Price-358.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$11.34M
Net Margin-1181.7%
Return on Equity-47.2%
Current Ratio6.16
Revenue Growth (YoY)34.2%
EPS Growth (YoY)-99.9%
FCF Growth (YoY)13986.8%
Financial Health — source: SEC EDGAR
Altman Z-Score8.70 (safe)
Valuation vs Sector & Industry
Stock P/E-0.0
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-100.1%
vs Industry-100.1%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderCormorant Asset Management, LP ($160.01M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOEli Wallace
Employees62
CountryUS
IPO Date2025-08-12

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Erasca, Inc. (ERAS)
  • NovaBridge Biosciences (NBP)
  • Intellia Therapeutics, Inc. (NTLA)
  • Phibro Animal Health Corporation (PAHC)
  • Monte Rosa Therapeutics, Inc. (GLUE)
  • AbCellera Biologics Inc. (ABCL)
  • Compass Therapeutics, Inc. (CMPX)
  • Bicara Therapeutics Inc. Common Stock (BCAX)
BBOT earnings history · BBOT institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.